167 related articles for article (PubMed ID: 12515290)
81. IgA antibodies against tissue transglutaminase, endomysium and gliadin in idiopathic polyneuropathy.
Vrethem M; Lindh J; Tondel M; Persson B; Dahle C
Acta Neurol Scand; 2013 Feb; 127(2):109-15. PubMed ID: 22651850
[TBL] [Abstract][Full Text] [Related]
82. The industrial food additive, microbial transglutaminase, mimics tissue transglutaminase and is immunogenic in celiac disease patients.
Matthias T; Jeremias P; Neidhöfer S; Lerner A
Autoimmun Rev; 2016 Dec; 15(12):1111-1119. PubMed ID: 27640315
[TBL] [Abstract][Full Text] [Related]
83. Immunoassays for the detection of IgA antibodies to tissue transglutaminase: significance of multiples of the upper limit of normal and inter-assay correlations.
Suh-Lailam BB; Davis KW; Tebo AE
Clin Chem Lab Med; 2016 Feb; 54(2):257-64. PubMed ID: 26172170
[TBL] [Abstract][Full Text] [Related]
84. Undetectable negative tissue transglutaminase IgA antibodies predict mucosal healing in treated coeliac disease patients.
Fang H; King KS; Larson JJ; Snyder MR; Wu TT; Gandhi MJ; Murray JA
Aliment Pharmacol Ther; 2017 Oct; 46(7):681-687. PubMed ID: 28782118
[TBL] [Abstract][Full Text] [Related]
85. Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age.
Maglio M; Tosco A; Paparo F; Auricchio R; Granata V; Colicchio B; Indolfi V; Miele E; Troncone R
J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):43-8. PubMed ID: 19934769
[TBL] [Abstract][Full Text] [Related]
86. Prevalence of coeliac disease in the adult population of central Greece.
Roka V; Potamianos SP; Kapsoritakis AN; Yiannaki EE; Koukoulis GN; Stefanidis I; Koukoulis GK; Germenis AE
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):982-7. PubMed ID: 18049168
[TBL] [Abstract][Full Text] [Related]
87. Increased IgA glycoprotein-2 specific antibody titres in refractory celiac disease.
Gross S; Bakker SF; van Bodegraven AA; van Hoogstraten IM; Gelderman KA; Bouma G; Mulder CJ; von Blomberg BM; Bontkes HJ
J Gastrointestin Liver Dis; 2014 Jun; 23(2):127-33. PubMed ID: 24949603
[TBL] [Abstract][Full Text] [Related]
88. Production of recombinant human tissue transglutaminase using the baculovirus expression system, and its application for serological diagnosis of coeliac disease.
Osman AA; Richter T; Stern M; Conrad K; Henker J; Brandsch C; Zimmer KP; Mothes T
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1217-23. PubMed ID: 12439116
[TBL] [Abstract][Full Text] [Related]
89. Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis.
Riente L; Chimenti D; Pratesi F; Delle Sedie A; Tommasi S; Tommasi C; Bombardieri S; Migliorini P
J Rheumatol; 2004 May; 31(5):920-4. PubMed ID: 15124251
[TBL] [Abstract][Full Text] [Related]
90. Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease.
Weiss B; Bujanover Y; Avidan B; Fradkin A; Weintraub I; Shainberg B
Isr Med Assoc J; 2004 Jan; 6(1):9-12. PubMed ID: 14740501
[TBL] [Abstract][Full Text] [Related]
91. Increased levels of IgA antibodies against desmin in children with coeliac disease.
Teesalu K; Uibo O; Kalkkinen N; Janmey P; Uibo R
Int Arch Allergy Immunol; 2001 Oct; 126(2):157-66. PubMed ID: 11729354
[TBL] [Abstract][Full Text] [Related]
92. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG.
Fabiani E; Catassi C;
Eur J Gastroenterol Hepatol; 2001 Jun; 13(6):659-65. PubMed ID: 11434591
[TBL] [Abstract][Full Text] [Related]
93. High levels of immunoglobulin A anti-tissue transglutaminase antibodies at diagnosis are a predictive factor for celiac hepatitis.
Albuquerque A; Rodrigues S; Macedo G
Scand J Gastroenterol; 2016 Nov; 51(11):1316-20. PubMed ID: 27387923
[TBL] [Abstract][Full Text] [Related]
94. Determination of IgG and IgA antibodies against native gliadin is not helpful for the diagnosis of coeliac disease in children up to 2 years old.
Richter T; Bossuyt X; Vermeersch P; Uhlig HH; Stern M; Hauer A; Zimmer KP; Mearin L; de Roo JH; Dähnrich C; Mothes T
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):21-5. PubMed ID: 22249805
[TBL] [Abstract][Full Text] [Related]
95. Evidence of Crohn's disease-related anti-glycoprotein 2 antibodies in patients with celiac disease.
Roggenbuck D; Vermeire S; Hoffman I; Reinhold D; Schierack P; Goihl A; von Arnim U; De Hertogh G; Polymeros D; Bogdanos DP; Bossuyt X
Clin Chem Lab Med; 2015 Aug; 53(9):1349-57. PubMed ID: 25411995
[TBL] [Abstract][Full Text] [Related]
96. Prevalence and characteristics of celiac disease in South African patients with type 1 diabetes mellitus: Results from the Durban Diabetes and Celiac Disease Study.
Paruk IM; Naidoo VG; Pirie FJ; Maharaj S; Nkwanyana NM; Dinnematin HL; Ganie Y; Ramdial PK; Motala AA
J Gastroenterol Hepatol; 2019 Apr; 34(4):673-678. PubMed ID: 30600564
[TBL] [Abstract][Full Text] [Related]
97. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
[TBL] [Abstract][Full Text] [Related]
98. Celiac disease and severe vitamin D deficiency: the case for anti-tissue transglutaminase antibody screening.
Sulimani RA
Arch Osteoporos; 2019 Mar; 14(1):30. PubMed ID: 30828751
[TBL] [Abstract][Full Text] [Related]
99. The association between de novo inflammatory bowel disease and celiac disease.
Manceñido Marcos N; Pajares Villarroya R; Salinas Moreno S; Arribas López MR; Comas Redondo C
Rev Esp Enferm Dig; 2020 Jan; 112(1):7-11. PubMed ID: 31718200
[TBL] [Abstract][Full Text] [Related]
100. Celiac disease-specific and inflammatory bowel disease-related antibodies in patients with recurrent aphthous stomatitis.
Bijelić B; Matić IZ; Besu I; Janković L; Juranić Z; Marušić S; Andrejević S
Immunobiology; 2019 Jan; 224(1):75-79. PubMed ID: 30446336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
